Rapamycin

A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.

300 PubMed studies analyzed · 4 RCTs · Evidence Score: 45.4

Research Domains

Rapamycin has been studied across 22 research domains including ⏳ Longevity & Aging, 🔬 Oncology, 🛡️ Immunity, 🏋️ Muscle & Hypertrophy, 🔥 Metabolic. The primary research focus is ⏳ Longevity & Aging with 59% of studies addressing this area.

Loading evidence profile...

This evidence profile for Rapamycin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.